K. Nagashima

发表

β chemical inhibitor of IKK Rapid TNFR1 dependent lymphocyte depletion in vivo with a selective

M. Hepperle, Gerry Harriman, B. Jaffee, 2013 .

Rapid TNFR1-dependent lymphocyte depletion in vivo with a selective chemical inhibitor of IKKbeta.

V. Sasseville, M. Hepperle, Gerry Harriman, 2006, Blood.

Development of a High-Throughput Gene Expression Screen for Modulators of RAS-MAPK Signaling in a Mutant RAS Cellular Context

Marc Ferrer, Michelle A Cleary, Michael D Altman, 2016, Journal of biomolecular screening.

A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors

C. Paweletz, H. Dai, I. Feldman, 2010, BMC Medical Genomics.

High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice

Susumu Tonegawa, S. Tonegawa, M. Katsuki, 1994, Cell.

PDK1 attenuation fails to prevent tumor formation in PTEN-deficient transgenic mouse models.

K. Kunii, R. Bronson, M. Scott, 2011, Cancer research.

Therapeutics , Targets , and Chemical Biology PDK 1 Attenuation Fails to Prevent Tumor Formation in PTEN-Deficient Transgenic Mouse Models

Hare, K. Kunii, R. Bronson, 2011 .

Genetic and Pharmacological Inhibition of PDK1 in Cancer Cells

C. Paweletz, Youwei Yan, M. Wiznerowicz, 2010, The Journal of Biological Chemistry.

Development of High-Throughput TR-FRET and AlphaScreen® Assays for Identification of Potent Inhibitors of PDK1

I. Kariv, T. Rush, J. Andersen, 2009, Journal of biomolecular screening.

Sensitive multiplexed analysis of kinase activities and activity-based kinase identification

S. Gygi, C. Paweletz, J. Villén, 2009, Nature Biotechnology.

Identification of Direct Target Engagement Biomarkers for Kinase-Targeted Therapeutics

R. Hendrickson, C. Paweletz, P. Blume-Jensen, 2011, PloS one.

Intracellular distribution of the antimutagenic enzyme MTH1 in the liver, kidney and testis of F344 rats and its modulation by cadmium.

J. Ward, Y. Nakabeppu, M. Sekiguchi, 2001, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

Evaluating TBK1 as a Therapeutic Target in Cancers with Activated IRF3

H. Hirsch, Kwok-Kin Wong, P. Janne, 2014, Molecular Cancer Research.

Participation of Rip2 in Lipopolysaccharide Signaling Is Independent of Its Kinase Activity*

Chafen Lu, B. Jaffee, T. Ocain, 2005, Journal of Biological Chemistry.

Altered peptidase and viral-specific T cell response in LMP2 mutant mice.

S. Tonegawa, A. Goldberg, M. Eichelberger, 1994, Immunity.

Signal Transduction Evaluating TBK 1 as a Therapeutic Target in Cancers with Activated IRF 3

Kwok-Kin Wong, L. Zawel, P. Kirschmeier, 2015 .

Comparison of the timing of acute blood‐brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune encephalomyelitis

Robbie Robertson, B. Keyt, K. Nagashima, 2001, The Journal of comparative neurology.

Pillars article: High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell. 1994. 78: 399-408.

S. Tonegawa, M. Katsuki, K. Nagashima, 2013, Journal of Immunology.

articleA gene expression signature of RAS pathway dependence predicts response to PI 3 K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors

C. Paweletz, H. Dai, I. Feldman, 2010 .

articleA gene expression signature of RAS pathway dependence predicts response to PI 3 K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors

C. Paweletz, H. Dai, I. Feldman, 2010 .